Amelubant
Amelubant (also known by its code BIIL 284 BS) is an investigational small-molecule drug that acts as a long-acting oral leukotriene B4 (LTB4) receptor antagonist. It was developed by Boehringer Ingelheim for the treatment of inflammatory and respiratory diseases. Reference standards of Amelubant API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Amelubant
[catalogue_number] => PA 01 4140000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 538.64
[form] => C33H34N2O5
[cas] => 346735-24-8
[pslug] => 346735-24-8-amelubant-pa014140000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 01 4140000
Molecular Formula : C33H34N2O5
Molecular Weight : 538.64
